-
Mashup Score: 1
Dr. Porcu discusses his path to focusing on lymphoma and how mentors helped him along the way.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 4
Melody Smith, MD, MS, talks about her journey to becoming a physician-scientist.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
Today is #InternationalMuseumDay ποΈ Fun fact: @MelodySmithMD, of @StanfordMed, would've been a museum curator if she didn't pursue science and medicine! Check out her Get to Know interview & learn some more tidbits about your day-to-day hem-oncs π π https://t.co/QgSyb24hIL https://t.co/iD2eF7B1kk
-
-
Mashup Score: 1Epigenetic Signature Could Improve Prediction of MBL Progression | Blood Cancers Today - 2 day(s) ago
The ELCLV3-21 Β high-risk signature distinguished those with MBL with a high probability of progression
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Hematologic Oncology News | Blood Cancers Today - 2 day(s) ago
Blood Cancers Today provides hematologists and oncologists with news, education, and information relevant to their patients and practices, featuring exclusive expert interviews.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13
In the first segment of the roundtable series, the panel discusses how myelofibrosis is diagnosed and assessed.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Using data from CLL long-term cultures, the researchers found that TBX21 expression was induced in CLL cells.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Liso-Cel βFavorableβ Safety Profile in Second-line Follicular Lymphoma | Blood Cancers Today - 3 day(s) ago
At a median follow-up of 18.1 months, the ORR and CR rates were both 95.7% following liso-cel treatment.
Source: bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6
Dr. Hilal covers the debates surrounding MRD, whether he uses MRD to make treatment decisions, and more.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5
Monotherapy with tagraxofusp induced complete remissions in patients with blastic plasmacytoid dendritic cell neoplasm.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6
Dr. Hilal covers the debates surrounding MRD, whether he uses MRD to make treatment decisions, and more.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
π΄ May is #NationalBikeMonth! Did you know that biking is a common hobby in the hem-onc community? "Biking is at the core of my mind-body connection experience," Dr. Pierluigi Porcu, of @KimmelCancerCtr, told us in his Get to Know. π° Check it out here! https://t.co/M8TAp006k5 https://t.co/dEqwIgM4YD